Jury Awards $1.7 Million to Levaquin Plaintiff



DOCUMENTS
  • Complaint
  • Jury Verdict


MINNEAPOLIS - A federal jury has awarded a plaintiff $1.7 million in the first Levaquin injury case to go to trial, finding that Ortho-McNeil-Janssen and its parent company, Johnson & Johnson, failed to adequately warn patients that the drug may cause tendon damage. Schedin v. Johnson & Johnson, et al., No. 08-05743 (D. Minn.).

After a three-week trial, the U.S. District Court for the District of Minnesota jury on Dec. 8 awarded John Schedin $1.1 million in punitive damages and $63,000 in compensatory damages. The jury answered "yes" to the question, "By clear and convincing evidence, did defendant act with …






UPCOMING CONFERENCES




HarrisMartin's New Jersey Asbestos Litigation Conference

March 03, 2023 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS



HarrisMartin's MDL Conference: Managing Mass Torts, Status of Key Litigations and Lessons Learned

March 29, 2023 - Tucson, AZ
Hotel Details in Tucson, Arizona, to be Announced

MORE DETAILS